Japan· JP-3999434A1026
カナキヌマブ（遺伝子組換え）
A medicinal product containing カナキヌマブ（遺伝子組換え）, registered in Japan by ノバルティス ファーマ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- カナキヌマブ（遺伝子組換え）
- Manufacturer
- ノバルティス ファーマ
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
カナキヌマブ（遺伝子組換え） in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaILARISNovartis Europharm Limited, Dublin
- SwedenIlaris 150 mg Injektionsvätska, lösning i förfylld injektionspennaNovartis Europharm Limited
- BelgiumIlaris 150 mgNovartis Europharm
- United KingdomIlaris 150mg powder for solution for injection vialsNovartis Pharmaceuticals UK Ltd
- FinlandIlarisNovartis Europharm Limited
- IcelandIlarisNovartis Europharm Limited*
- PolandIlarisNovartis Europharm Limited
- SpainILARIS 150 mg POLVO PARA SOLUCION INYECTABLENovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ilaris
- Liechtenstein · Ilaris
- Norway · Ilaris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/559493df-2f88-4a19-bd57-63aa87b16ad4 GET /v1/drugs/559493df-2f88-4a19-bd57-63aa87b16ad4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１５０ｍｇ１ｍＬ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999434A1026",
"category": "注射薬",
"price_yen": 1144556,
"generic_name": "カナキヌマブ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about カナキヌマブ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.